The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Strong recovery from Revolution Bars, Vitec

Tue, 01st Mar 2022 18:09

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

PPHE Hotel Group Ltd - Amsterdam-based hotel owner and operator - For 2021, pretax loss narrows to GBP57.6 million from GBP94.7 million the year before, on revenue which grows 39% year-on-year to GBP141.4 million from GBP101.8 million, which marks a recovery to 40% of company's 20219 levels. RevPAR rises 22% to GBP35.9 from GBP29.4, and occupancy improves to 30.7% from 28.0% the prior year. Stronger performance is buoyed by the vaccination rollout in several countries, and the easing of Covid-related restrictions from the second quarter onwards. Will not declare a dividend for 2021, but will review future payouts depending on the recovery trajectory.

----------

Vitec Group PLC - Richmond, west London-based photography and video products maker - For 2021, swings to pretax profit of GBP29.6 million from a loss of GBP7.7 million, on revenue which grows 36% year-on-year to record levels of GBP394.3 million from GBP290.5 million, with increases across all divisions reflecting a strong market recovery. Declares final dividend of 24.0 pence per share, bringing the total payout to 35.0p, hiked from 4.5p. Looking ahead, Vitec says 2022 started well with record order intake, and remains confident despite short-term component shortages and inflation. Also looking to change group name at 2022 annual general meeting.

----------

Revolution Bars Group PLC - Ashton-under-Lyne, England-based bar chain - For the 26 weeks ended January 1, swings to pretax profit of GBP4.3 million from loss of GBP17.7 million the same period a year before, as total sales more than triple to GBP74.1 million from GBP21.6 million, aided by relaxed restrictions, allowing the return of students, office workers and increased staycations. Looking ahead, return to like-for-like sales growth in February, and expects annual adjusted earnings before interest, tax, depreciation and amortisation to be at the top end of market expectations, which is set between GBP8.0 million and GBP10.0 million.

----------

Volvere PLC - turnaround investment firm based in Leamington Spa, England - For 2021, expects to report a pretax profit of around GBP70,000, swinging from a loss of GBP550,000 the year before, on revenue which is set to grow 16% year-on-year to GBP35.6 million from GBP30.8 million, driven by a stronger performance from Shire Foods and Indulgence Patisserie Ltd. Looking ahead, challenges related to cost increases and labour availability in 2021 are present in 2022, however, environment for turnaround investing is improving.

----------

Uniphar PLC - Dublin-based healthcare services firm - For 2021, pretax profit increases 32% to EUR50.4 million from EUR38.4 million, on revenue which grows 6.5% year-on-year to EUR1.94 billion from EUR1.82 billion, with growth from all businesses, particularly Supply Chain & Retail which exceeds gross profit guidance. Looking ahead, keeps medium term guidance of mid-single digit growth in Commercial & Clinical, double-digit from Product Access and low-single digit in Supply Chain & Retail.

----------

essensys PLC - London-based software and cloud services for flexible workspace industry - For the six months ended January 31, revenue increases 3% year-on-year to GBP10.9 million, with continued demand from existing and new customers. Leads to anticipation that adjusted loss before interest, tax, depreciation and amortisation will be slightly better than management expectations. Looking ahead, to full year, adjusted Lbitda is set to be no more than GBP7 million, and revenue is expected to be at least GBP23.5 million, up 6.8% from GBP22 million the prior year. However, expansion and acceleration of its go-to-market activities has been delayed by "continued Covid related uncertainty". Also results in extended sales cycles leading to lower-than-anticipated sales bookings year-to-date.

----------

Fiske PLC - London-based stockbroker and investment manager - For the six months ended November 30, pretax loss narrows to GBP6,000 from GBP103,000 the same period a year before, as revenue grows 6% year-on-year to GBP2.9 million from GBP2.7 million, driven by a rise in investment management fee income on new client wins, more than offsetting a drop in commission income as market conditions were less volatile.

----------

PCI-PAL PLC - London-based call centre software provider - For the six months ended December 31, pretax loss narrows to GBP1.1 million from GBP2.3 million, on revenue which grows 72% year-on-year to GBP5.5 million from GBP3.2 million, as total annual contract value rises 36% to GBP11.3 million from GBP8.3 million. Looking ahead, makes strong start to the second half, with revenue momentum and the launch of its Australian business.

----------

Calnex Solutions PLC - provider of test and measurement solutions for the telecommunications sector - Reports strong levels of trading in the six months ending September 31, and subject to the fulfilment of scheduled orders in March, results for the year ending March 31 are set to e in line with market expectations. Calnex is on-track to begin the 2023 financial year with a record order book across all product lines, leading to revenue and operating profit for the year being set to come ahead of market expectations.

----------

European Smaller Companies Trust PLC - fund that seeks capital growth by investing in smaller companies in Europe outside the UK - For the six months ended December 31, net asset value total return is negative 1.4%, compared to the Euromoney Smaller European Cos (ex-UK) index, which made a positive return of 4.1%. As at December 31, net asset value per share drops 2.4% to 204.69 pence from 209.71p at the end of June. Declares dividend per share of 1.25 pence, up 22% from 1.025p a year prior.

----------

GetBusy PLC - Cambridge, England-based document management and productivity software provider - For 2021, pretax loss widens to GBP2.3 million from GBP1.1 million on rising costs, which more than offset a 8.5% rise in revenue to GBP15.4 million from GBP14.2 million, as annual recurring revenue grows 16% to GBP15.8 million, due to new business and ongoing demand. Looking ahead, for 2022 adjusted Ebitda is expected to approach breakeven, while strong ARR momentum will have group revenue at no less than GBP17.0 million.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis - For the six months ended December 31, pretax loss widens to AUD7.6 million from AUD5.9 million, due to higher administrative costs and one-off impairments arising from the MedicaNL acquisition. This was in spite of revenue more than tripling to AUD2.6 million from AUD741,911 through strong sales of Artemic, its Covid-19 supplement.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 Feb 2023 11:01

MGC receives USD600,000 funding; changes chief financial officer

(Alliance News) - MGC Pharmaceuticals Ltd on Friday said it received USD600,000 in funding provided by Mercer Street Capital Partners LLC, while it has appointed a new chief financial officer.

Read more
2 Feb 2023 19:39

TRADING UPDATES: Lords sells business; Atome wins joint venture deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jan 2023 16:23

TRADING UPDATES: DP Eurasia annual sales grow despite Russia decline

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Jan 2023 09:30

CORRECT: Getech signs deal; AfriTin confirms name change

(Corrects that Zenith Energy is based in Canada, not in Scotland.)

Read more
10 Jan 2023 21:34

TRADING UPDATES: Getech signs deal; AfriTin confirms name change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 Jan 2023 17:17

TRADING UPDATES: MGC cuts costs; Ince gets Arden sale green light

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Dec 2022 09:45

IN BRIEF: MGC Pharma receives AUD800,000 funding from Mercer Street

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Secures AUD800,000 in funding under USD10 million convertible securities financing facility agreement signed with Mercer Street Global Opportunity Fund LLC, a fund managed by Mercer Street Capital Partners. Under the terms of the facility, MGC will issue Mercer 586,432 convertible notes with a face value of USD1.0 each. The company said the funding will be used as working capital for "ongoing operations", including its clinical trials programme.

Read more
5 Dec 2022 14:09

IN BRIEF: MGC Pharmaceuticals delivers USD1 million order of ArtemiC

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes the delivery of its "largest" order of ArtemiC Rescue to US distribution and marketing partner, AMC Holdings Inc. Says the order is worth USD1.0 million and was delivered in a single shipment.

Read more
17 Nov 2022 15:48

UK shareholder meetings calendar - next 7 days

Friday 18 November 
MJ Gleeson PLCAGM
Just Eat Takeaway.com N.V.EGM
Marula Mining PLCAGM
NIOX Group PLCGM share premium account cancellation
Sovereign Metals LtdAGM
Monday 21 November 
Manchester & London Investment Trust PLCAGM
Mountview Estates PLCGM re re-electing Chair Powell, non-exec Archibald
RPS Group PLCGM cash offer agreement
Yamana Gold IncGM Gold Fields offer
Tuesday 22 November 
Alpha FX Group PLCGM re name change
Artemis Resources LtdAGM
Fonix Mobile PLCAGM
Kingswood Holdings LtdAGM
Origin Enterprises PLCAGM
Physiomics PLCAGM
Quantum Exponential Group PLCAGM
Rainbow Rare Earths LtdAGM
Sabien Technology Group PLCAGM
Town Centre Securities PLCAGM
Wednesday 23 November 
Crystal Amber Fund LtdAGM
CVS Group PLCAGM
Fidelity Asian Values PLCAGM
Genus PLCAGM
JPMorgan Russian Securities PLCGM re name change
Synergia Energy LtdAGM
Wilmington PLCAGM
Woolworths Holdings LtdAGM
Thursday 24 November 
Cloudbreak Discovery PLCAGM
EnSilica PLCAGM
Fiske PLCAGM
MGC Pharmaceuticals LimitedAGM
Pacific Horizon Investment Trust PLCAGM
Pan African Resources PLCAGM
PZ Cussons PLCAGM
Zanaga Iron Ore Co LtdAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 Oct 2022 14:53

TRADING UPDATES: Gunsynd invests; AQRU launches crypto-backed loans

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
4 Oct 2022 11:07

IN BRIEF: MGC Pharmaceuticals appoints Yifat Steuer deputy CEO

MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Appoints Yifat Steuer as the company's new chief operating officer and deputy chief executive officer. Steuer has worked across a range of pharmaceutical companies, including Johnson & Johnson, GSK PLC as well as with start-ups. The company said that Brett Mitchell has moved from executive chair to non-executive chair "to be more in line with corporate structuring of UK listed companies."

Read more
28 Sep 2022 16:05

UK shareholder meetings calendar - next 7 days

Thursday 29 September 
ActiveOps PLCAGM
Chill Brands Group PLCAGM
Coral Products PLCAGM
Echo Energy PLCGM re approval of annual report
Jaywing PLCGM re funding
Orient Telecoms PLCAGM
President Energy PLCGM proposed capital reorganisation
Samarkand Group PLCAGM
TransGlobe Energy CorpGM re merger with Vaalco Energy Inc
Ted Baker PLCGM re shareholders vote on acquisition by ABG 
Vaalco Energy IncGM re merger with TransGlobe Energy Corp
Van Elle Holdings PLCAGM
Walker Crips Group PLCAGM
Friday 30 September 
Capital Metals PLCAGM
Henderson Smaller Companies Investment Trust PLCAGM
Ince Group PLCAGM
Indivior PLCGM additional US listing
Insig AI PLCGM financial outcomes
Libertine Holdings PLCAGM
MiLOC Group LtdAGM
Oakley Capital Investments LtdAGM
OptareAGM
Pennpetro Energy PLCAGM
Saietta Group PLCAGM
TMT Acquisition PLCAGM
TPXimpact Holdings PLCAGM
Versarien PLCAGM
Monday 3 October 
Jupiter Emerging & Frontier Income Trust PLCGM re amending redemption facility
Kape Technologies PLCGM re fundraise
Tuesday 4 October 
Henderson Diversified Income TrustAGM
Wednesday 5 October 
Goodwin PLCAGM
Hambro Perks Acquisition Co LtdAGM
MGC Pharmaceuticals LtdGM convertible securities agreement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Sep 2022 12:23

MGC Pharmaceuticals shares down on advertising fine in Australia

(Alliance News) - MGC Pharmaceuticals Ltd on Wednesday said it faces 23 infringement notices worth AUD306,960, around GBP185,470, for contravening therapeutic goods advertising laws.

Read more
23 Sep 2022 13:43

IN BRIEF: MGC Pharma receives USD550,000 more from Mercer Street

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives a further USD550,000 under the USD10 million financing agreement signed with Mercer Street Global Opportunity Fund LLC, a fund managed by Mercer Street Capital Partner. Under the terms of the agreement, announced in July, MGC Pharma will now issue Mercer 605,000 convertible notes with a face value of USD1.00 each. The funds received will be used to fund MGC's ongoing operations such as clinical trials.

Read more
21 Sep 2022 17:53

IN BRIEF: MGC notes "encouraging" results from CimetrA study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says interim results from the CimetrA study show no significant Covid-19 related complications, compared to 63% of placebo group who reported adverse events related to Covid-19 symptoms. The study had 16 participants with Covid-19. No patients from either drug study group showed any Covid-19 related adverse events, it noted. It also notes improvements in multiple parameters measuring the patient's clinical condition, such as respiratory rate and oxygen saturation, when compared to placebo.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.